These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29118764)

  • 21. Folic acid mitigates angiotensin-II-induced blood pressure and renal remodeling.
    Pushpakumar SB; Kundu S; Metreveli N; Sen U
    PLoS One; 2013; 8(12):e83813. PubMed ID: 24386282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Folic acid 5 or 15 mg/d similarly reduces plasma homocysteine in patients with moderate-advanced chronic renal failure.
    Bernasconi AR; Liste A; Del Pino N; Rosa Diez GJ; Heguilén RM
    Nephrology (Carlton); 2006 Apr; 11(2):137-41. PubMed ID: 16669976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects.
    Ventura P; Panini R; Verlato C; Scarpetta G; Salvioli G
    Metabolism; 2001 Dec; 50(12):1466-71. PubMed ID: 11735095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folic acid enhances the cardiovascular protective effect of amlodipine in renal hypertensive rats with elevated homocysteine.
    Li L; Tong X; Ma Z; Lv L; Liu H; Chen GL
    Clin Exp Hypertens; 2023 Dec; 45(1):2205058. PubMed ID: 37154141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Contribution of Homocysteine Metabolism Disruption to Endothelial Dysfunction: State-of-the-Art.
    Esse R; Barroso M; Tavares de Almeida I; Castro R
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of Folic Acid Therapy in Patients with Hyperhomocysteinemia.
    Tian H; Tian D; Zhang C; Wang W; Wang L; Ge M; Hou Q; Zhang W
    J Am Coll Nutr; 2017; 36(7):528-532. PubMed ID: 28854002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Folic acid and vitamin B(12) supplementation attenuates isoprenaline-induced myocardial infarction in experimental hyperhomocysteinemic rats.
    Hagar HH
    Pharmacol Res; 2002 Sep; 46(3):213-19. PubMed ID: 12220963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is folate a promising agent in the prevention and treatment of cardiovascular disease in patients with renal failure?
    De Vriese AS; Verbeke F; Schrijvers BF; Lameire NH
    Kidney Int; 2002 Apr; 61(4):1199-209. PubMed ID: 11918726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation of programmed cell death in circulating neutrophils and its special characteristics in experimentally induced hyperhomocysteinemia in a setting of thyroid dysfunction.
    Nechyporuk V; Korda M; Pentiuk L; Kovalchuk O; Andriichuk V
    Pol Merkur Lekarski; 2020 Dec; 48(288):437-442. PubMed ID: 33387433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NRP1 regulates HMGB1 in vascular endothelial cells under high homocysteine condition.
    Ma Y; Zhang Z; Chen R; Shi R; Zeng P; Chen R; Leng Y; Chen AF
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1039-H1046. PubMed ID: 30767669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High Prevalence of Hyperhomocysteinemia and Its Association with Target Organ Damage in Chinese Patients with Chronic Kidney Disease.
    Ye Z; Zhang Q; Li Y; Wang C; Zhang J; Ma X; Peng H; Lou T
    Nutrients; 2016 Oct; 8(10):. PubMed ID: 27775590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homocysteine and diabetes: Role in macrovascular and microvascular complications.
    Muzurović E; Kraljević I; Solak M; Dragnić S; Mikhailidis DP
    J Diabetes Complications; 2021 Mar; 35(3):107834. PubMed ID: 33419630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Folic Acid and Vitamin B12 Administration in CKD, Why Not?
    Capelli I; Cianciolo G; Gasperoni L; Zappulo F; Tondolo F; Cappuccilli M; La Manna G
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30781775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resveratrol: A new approach to ameliorate hyperhomocysteinaemia-induced renal dysfunction.
    Zhao X; Hui QC; Xu R; Gao N; Cao P
    Exp Ther Med; 2022 Aug; 24(2):510. PubMed ID: 35837032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential role of homocysteine mediated DNA methylation and associated epigenetic changes in abdominal aortic aneurysm formation.
    Krishna SM; Dear A; Craig JM; Norman PE; Golledge J
    Atherosclerosis; 2013 Jun; 228(2):295-305. PubMed ID: 23497786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low Dose of Folic Acid Can Ameliorate Hyperhomocysteinemia-Induced Cardiac Fibrosis and Diastolic Dysfunction in Spontaneously Hypertensive Rats.
    Cao P; Zhang W; Wang G; Zhao X; Gao N; Liu Z; Xu R
    Int Heart J; 2021 May; 62(3):627-635. PubMed ID: 33994505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperhomocysteinemia and atherosclerosis.
    Yang F; Tan HM; Wang H
    Sheng Li Xue Bao; 2005 Apr; 57(2):103-14. PubMed ID: 15830093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homocysteine-lowering therapy with folic acid is effective in cardiovascular disease prevention in patients with kidney disease: a meta-analysis of randomized controlled trials.
    Qin X; Huo Y; Xie D; Hou F; Xu X; Wang X
    Clin Nutr; 2013 Oct; 32(5):722-7. PubMed ID: 23313356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prevalence of hyperhomocysteinemia, methylene tetrahydrofolate reductase C677T mutation, and vitamin B12 and folate deficiency in patients with chronic venous insufficiency.
    Sam RC; Burns PJ; Hobbs SD; Marshall T; Wilmink AB; Silverman SH; Bradbury AW
    J Vasc Surg; 2003 Nov; 38(5):904-8. PubMed ID: 14603192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse myocardial effects of B-vitamin therapy in subjects with chronic kidney disease and hyperhomocysteinaemia.
    Rafeq Z; Roh JD; Guarino P; Kaufman J; Joseph J
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):836-42. PubMed ID: 22902185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.